Healthcare Services

Rising Obesity Rates And Their Impact On The Growth Of The Orlistat Market Is Supporting Development Across The Orlistat Market

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Will Be The Estimated Market Size Of The Orlistat Market By 2030?

The orlistat market has experienced substantial growth in recent years. It is projected to expand from $3.2 billion in 2025 to $3.4 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. The growth observed in the past can be linked to the increasing prevalence of obesity and overweight populations, enhanced clinical acceptance of orlistat, broader availability of over-the-counter (OTC) orlistat, intensified health awareness campaigns targeting obesity, and the early integration of orlistat within developed markets.

The orlistat market is projected to experience robust expansion over the coming years. This market is set to reach $4.32 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.1%. This anticipated growth is driven by several factors, including the increasing uptake of orlistat in developing regions, a greater inclination towards non-surgical obesity solutions, its enhanced incorporation into weight management strategies, an uptick in healthcare campaigns aimed at obesity prevention, and improvements in drug formulation and delivery technologies. Key trends anticipated during this period encompass the increased use of orlistat as a therapeutic option for weight control, a heightened demand for both prescription and over-the-counter orlistat products, a stronger emphasis on integrating orlistat with lifestyle changes, a surge in the need for weight loss solutions that complement low-fat diets, and a broader understanding of obesity management and preventative measures.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18422&type=smp

Which Growth Drivers Are Expected To Support The Orlistat Market Forward?

The escalating rates of obesity are anticipated to drive the development of the orlistat market moving forward. Obesity is a medical condition defined by the excessive accumulation of body fat, which can adversely affect health. It is typically assessed using a body mass index (BMI) of 30 or higher. The increase in obesity is attributable to factors such as poor dietary habits, insufficient physical activity, and sedentary lifestyles. Orlistat is utilized in obesity management by inhibiting the absorption of dietary fats, thereby aiding in body weight reduction and the maintenance of weight loss. For enhanced efficacy, it is frequently prescribed in conjunction with a reduced-calorie diet and regular exercise. As an illustration, a 2024 report from the UK-based non-profit organization, the World Obesity Federation, projects that by 2035, a substantial 79% of adults who are overweight or obese will reside in Low- and Middle-Income Countries (LMICs). Moreover, the same report indicates that 88% of children categorized as overweight or obese will also be living in LMICs by 2035. Consequently, the rising incidence of obesity is acting as a significant impetus for the growth of the orlistat market.

How Is The Orlistat Market Structured Across Different Market Segments?

The orlistat market covered in this report is segmented –

1) By Type: 120 Milligram (Mg), 60 Milligram (Mg)

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By Application: Weight-Reducing Aid, Other Applications

Subsegments:

1) By 120 Milligram (Mg): Prescription-Based 120 Mg Orlistat, Over-The-Counter (OTC) 120 Mg Orlistat

2) By 60 Milligram (Mg): Over-The-Counter (OTC) 60 Mg Orlistat, Prescription-Based 60 Mg Orlistat

What Trends Are Affecting The Growth Of The Orlistat Market?

Companies operating in the `organoids and spheroids market` are concentrating on developing sophisticated solutions, such as single-particle dispensers, to improve precision in cell handling and enhance the reproducibility of research outcomes. Single-particle dispensers are highly accurate instruments engineered for isolating and distributing individual cells or particles, enabling precise control and manipulation in research and diagnostic applications. For instance, in `July 2024`, `SEED Biosciences`, a Switzerland-based biotechnology company, introduced `Dispen3D`, a revolutionary tool designed for the accurate dispensing of individual spheroids and organoids, marking a significant breakthrough in the handling of 3D cellular models. Researchers can now swiftly and precisely transfer single spheroids into multi-well plates with this novel dispenser, which automates the procedure and ensures monoclonality, crucial for drug discovery and customized treatment. `Dispen3D` delicately treats fragile cells while maintaining their structural integrity and vitality by operating at low pressures. Its user-friendly design makes it simple to implement in a variety of research contexts, satisfying the growing need for cutting-edge instruments in the biological sciences.

Which Organizations Are Involved In The Orlistat Market?

Major companies operating in the orlistat market are Merck & Co. Inc., GlaxoSmithKline plc, Roche Holding AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Dr Reddys Laboratories Ltd., Cipla Ltd., Intas Pharmaceuticals Ltd., Lupin Pharmaceuticals Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Zydus Life, Emcure Pharmaceuticals Ltd., Lannett Company Inc., Strides Pharma Science Ltd., Indoco Remedies Ltd., Wockhardt Ltd., Jubilant Life Sciences Ltd., Aurobindo Pharma Ltd.

Access The Complete Orlistat Market Report:

https://www.thebusinessresearchcompany.com/report/orlistat-global-market-report

Which Region Is The Dominant Market In The Orlistat Market?

North America was the largest region in the orlistat market in 2025. The regions covered in the orlistat market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Orlistat Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=18422&type=smp

Browse Through More Reports Similar to the Global Orlistat Market 2026, By The Business Research Company

Organoids And Spheroids Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report

Organometallics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/organometallics-global-market-report

Artificial Organ Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/artificial-organ-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795